210 related articles for article (PubMed ID: 24967665)
1. A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo.
Lewis ND; Patnaude LA; Pelletier J; Souza DJ; Lukas SM; King FJ; Hill JD; Stefanopoulos DE; Ryan K; Desai S; Skow D; Kauschke SG; Broermann A; Kuzmich D; Harcken C; Hickey ER; Modis LK
PLoS One; 2014; 9(6):e100883. PubMed ID: 24967665
[TBL] [Abstract][Full Text] [Related]
2. G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype.
Högenauer K; Arista L; Schmiedeberg N; Werner G; Jaksche H; Bouhelal R; Nguyen DG; Bhat BG; Raad L; Rauld C; Carballido JM
J Med Chem; 2014 Dec; 57(24):10343-54. PubMed ID: 25411721
[TBL] [Abstract][Full Text] [Related]
3. TUDCA: An Agonist of the Bile Acid Receptor GPBAR1/TGR5 With Anti-Inflammatory Effects in Microglial Cells.
Yanguas-Casás N; Barreda-Manso MA; Nieto-Sampedro M; Romero-Ramírez L
J Cell Physiol; 2017 Aug; 232(8):2231-2245. PubMed ID: 27987324
[TBL] [Abstract][Full Text] [Related]
4. The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis.
Biagioli M; Carino A; Cipriani S; Francisci D; Marchianò S; Scarpelli P; Sorcini D; Zampella A; Fiorucci S
J Immunol; 2017 Jul; 199(2):718-733. PubMed ID: 28607110
[TBL] [Abstract][Full Text] [Related]
5. Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells.
Kida T; Tsubosaka Y; Hori M; Ozaki H; Murata T
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1663-9. PubMed ID: 23619297
[TBL] [Abstract][Full Text] [Related]
6. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice.
Wang YD; Chen WD; Yu D; Forman BM; Huang W
Hepatology; 2011 Oct; 54(4):1421-32. PubMed ID: 21735468
[TBL] [Abstract][Full Text] [Related]
7. Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease.
McMahan RH; Wang XX; Cheng LL; Krisko T; Smith M; El Kasmi K; Pruzanski M; Adorini L; Golden-Mason L; Levi M; Rosen HR
J Biol Chem; 2013 Apr; 288(17):11761-70. PubMed ID: 23460643
[TBL] [Abstract][Full Text] [Related]
8. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
[TBL] [Abstract][Full Text] [Related]
9. Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis.
Carino A; Marchianò S; Biagioli M; Bucci M; Vellecco V; Brancaleone V; Fiorucci C; Zampella A; Monti MC; Distrutti E; Fiorucci S
FASEB J; 2019 Feb; 33(2):2809-2822. PubMed ID: 30303744
[TBL] [Abstract][Full Text] [Related]
10. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
[TBL] [Abstract][Full Text] [Related]
11. A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.
Carrillo-Salinas FJ; Navarrete C; Mecha M; Feliú A; Collado JA; Cantarero I; Bellido ML; Muñoz E; Guaza C
PLoS One; 2014; 9(4):e94733. PubMed ID: 24727978
[TBL] [Abstract][Full Text] [Related]
12. An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation.
Hohenhaus DM; Schaale K; Le Cao KA; Seow V; Iyer A; Fairlie DP; Sweet MJ
Immunobiology; 2013 Nov; 218(11):1345-53. PubMed ID: 23948647
[TBL] [Abstract][Full Text] [Related]
13. Lipid Receptor G2A-Mediated Signal Pathway Plays a Critical Role in Inflammatory Response by Promoting Classical Macrophage Activation.
Li Q; Feng C; Li L; Xu G; Gu H; Li S; Li D; Liu M; Han S; Zheng B
J Immunol; 2021 May; 206(10):2338-2352. PubMed ID: 33941654
[TBL] [Abstract][Full Text] [Related]
14. Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis.
Blasko E; Haskell CA; Leung S; Gualtieri G; Halks-Miller M; Mahmoudi M; Dennis MK; Prossnitz ER; Karpus WJ; Horuk R
J Neuroimmunol; 2009 Sep; 214(1-2):67-77. PubMed ID: 19664827
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury.
Biagioli M; Marchianò S; di Giorgio C; Roselli R; Bordoni M; Bellini R; Fiorillo B; Sepe V; Catalanotti B; Cassiano C; Monti MC; Distrutti E; Zampella A; Fiorucci S
Hepatology; 2023 Jul; 78(1):26-44. PubMed ID: 36107019
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.
Liu Y; Holdbrooks AT; De Sarno P; Rowse AL; Yanagisawa LL; McFarland BC; Harrington LE; Raman C; Sabbaj S; Benveniste EN; Qin H
J Immunol; 2014 Jan; 192(1):59-72. PubMed ID: 24323580
[TBL] [Abstract][Full Text] [Related]
17. Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.
Dagkonaki A; Avloniti M; Evangelidou M; Papazian I; Kanistras I; Tseveleki V; Lampros F; Tselios T; Jensen LT; Möbius W; Ruhwedel T; Androutsou ME; Matsoukas J; Anagnostouli M; Lassmann H; Probert L
Front Immunol; 2020; 11():575451. PubMed ID: 33329540
[TBL] [Abstract][Full Text] [Related]
18. Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.
Ullmer C; Alvarez Sanchez R; Sprecher U; Raab S; Mattei P; Dehmlow H; Sewing S; Iglesias A; Beauchamp J; Conde-Knape K
Br J Pharmacol; 2013 Jun; 169(3):671-84. PubMed ID: 23488746
[TBL] [Abstract][Full Text] [Related]
19. Sex-Specific Effects of Microglia-Like Cell Engraftment during Experimental Autoimmune Encephalomyelitis.
Han J; Zhu K; Zhou K; Hakim R; Sankavaram SR; Blomgren K; Lund H; Zhang XM; Harris RA
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957621
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
Ramroodi N; Khani M; Ganjali Z; Javan MR; Sanadgol N; Khalseh R; Ravan H; Sanadgol E; Abdollahi M
Immunol Invest; 2015; 44(7):694-712. PubMed ID: 26436854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
